Indivior (NASDAQ:INDV) Shares Gap Up to $20.57

Indivior PLC (NASDAQ:INDV)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $20.57, but opened at $21.22. Indivior shares last traded at $21.29, with a volume of 14,782 shares traded.

Indivior Stock Performance

The company has a 50 day moving average of $19.52 and a 200 day moving average of $18.58. The company has a quick ratio of 0.86, a current ratio of 0.97 and a debt-to-equity ratio of 2.02.

Indivior (NASDAQ:INDV) last posted its earnings results on Thursday, February 22nd. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.28 by $0.15. The company had revenue of $293.00 million during the quarter, compared to analyst estimates of $260.00 million. Indivior had a return on equity of 538.18% and a net margin of 0.18%. As a group, equities research analysts predict that Indivior PLC will post 2.03 earnings per share for the current year.

Institutional Investors Weigh In On Indivior

A number of institutional investors and hedge funds have recently modified their holdings of INDV. Vanguard Group Inc. raised its holdings in shares of Indivior by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock worth $90,081,000 after acquiring an additional 52,836 shares in the last quarter. Royal London Asset Management Ltd. raised its holdings in shares of Indivior by 5.8% during the fourth quarter. Royal London Asset Management Ltd. now owns 447,828 shares of the company’s stock worth $6,838,000 after acquiring an additional 24,383 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its holdings in shares of Indivior by 53.6% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 176,976 shares of the company’s stock worth $2,673,000 after acquiring an additional 61,772 shares in the last quarter. Madison Avenue Partners LP increased its position in Indivior by 84.9% during the fourth quarter. Madison Avenue Partners LP now owns 72,255 shares of the company’s stock worth $1,103,000 after buying an additional 33,168 shares during the last quarter. Finally, Legal & General Group Plc increased its position in Indivior by 158.1% during the fourth quarter. Legal & General Group Plc now owns 12,927 shares of the company’s stock worth $195,000 after buying an additional 7,919 shares during the last quarter. Institutional investors and hedge funds own 60.33% of the company’s stock.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.